ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines.

Clinical Genome Resource Consortium Clinical genetics Precision medicine Variant curation

Journal

Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844

Informations de publication

Date de publication:
18 01 2022
Historique:
received: 13 02 2021
accepted: 12 11 2021
entrez: 18 1 2022
pubmed: 19 1 2022
medline: 17 3 2022
Statut: epublish

Résumé

Identification of clinically significant genetic alterations involved in human disease has been dramatically accelerated by developments in next-generation sequencing technologies. However, the infrastructure and accessible comprehensive curation tools necessary for analyzing an individual patient genome and interpreting genetic variants to inform healthcare management have been lacking. Here we present the ClinGen Variant Curation Interface (VCI), a global open-source variant classification platform for supporting the application of evidence criteria and classification of variants based on the ACMG/AMP variant classification guidelines. The VCI is among a suite of tools developed by the NIH-funded Clinical Genome Resource (ClinGen) Consortium and supports an FDA-recognized human variant curation process. Essential to this is the ability to enable collaboration and peer review across ClinGen Expert Panels supporting users in comprehensively identifying, annotating, and sharing relevant evidence while making variant pathogenicity assertions. To facilitate evidence-based improvements in human variant classification, the VCI is publicly available to the genomics community. Navigation workflows support users providing guidance to comprehensively apply the ACMG/AMP evidence criteria and document provenance for asserting variant classifications. The VCI offers a central platform for clinical variant classification that fills a gap in the learning healthcare system, facilitates widespread adoption of standards for clinical curation, and is available at https://curation.clinicalgenome.org.

Sections du résumé

BACKGROUND
Identification of clinically significant genetic alterations involved in human disease has been dramatically accelerated by developments in next-generation sequencing technologies. However, the infrastructure and accessible comprehensive curation tools necessary for analyzing an individual patient genome and interpreting genetic variants to inform healthcare management have been lacking.
RESULTS
Here we present the ClinGen Variant Curation Interface (VCI), a global open-source variant classification platform for supporting the application of evidence criteria and classification of variants based on the ACMG/AMP variant classification guidelines. The VCI is among a suite of tools developed by the NIH-funded Clinical Genome Resource (ClinGen) Consortium and supports an FDA-recognized human variant curation process. Essential to this is the ability to enable collaboration and peer review across ClinGen Expert Panels supporting users in comprehensively identifying, annotating, and sharing relevant evidence while making variant pathogenicity assertions. To facilitate evidence-based improvements in human variant classification, the VCI is publicly available to the genomics community. Navigation workflows support users providing guidance to comprehensively apply the ACMG/AMP evidence criteria and document provenance for asserting variant classifications.
CONCLUSIONS
The VCI offers a central platform for clinical variant classification that fills a gap in the learning healthcare system, facilitates widespread adoption of standards for clinical curation, and is available at https://curation.clinicalgenome.org.

Identifiants

pubmed: 35039090
doi: 10.1186/s13073-021-01004-8
pii: 10.1186/s13073-021-01004-8
pmc: PMC8764818
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Subventions

Organisme : NIH HHS
ID : U41HG009649
Pays : United States
Organisme : NHGRI NIH HHS
ID : U41 HG006834
Pays : United States
Organisme : NIH HHS
ID : U01HG007436
Pays : United States
Organisme : NIH HHS
ID : U01HG007434
Pays : United States
Organisme : NHGRI NIH HHS
ID : U41 HG009649
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG009650
Pays : United States
Organisme : NIH HHS
ID : U41HG006834
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG009649
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG006834
Pays : United States
Organisme : NIH HHS
ID : U41HG009650
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Nucleic Acids Res. 2013 Jan;41(Database issue):D561-5
pubmed: 23175613
Bioinformatics. 2017 Feb 15;33(4):594-595
pubmed: 27742697
Nucleic Acids Res. 2019 Jan 8;47(D1):D786-D792
pubmed: 30304474
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Genet Med. 2018 Dec;20(12):1687-1688
pubmed: 29543229
Genet Med. 2018 Mar;20(3):351-359
pubmed: 29300372
Hum Mutat. 2018 Nov;39(11):1553-1568
pubmed: 30311375
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nucleic Acids Res. 2019 Jan 8;47(D1):D1018-D1027
pubmed: 30476213
Hum Mutat. 2018 Nov;39(11):1569-1580
pubmed: 30311390
Am J Hum Genet. 2016 Jun 2;98(6):1067-1076
pubmed: 27181684
Genome Biol. 2016 May 06;17(1):91
pubmed: 27154141
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
pubmed: 24234437
Genome Med. 2019 Dec 20;11(1):85
pubmed: 31862013
Nucleic Acids Res. 2020 Jan 8;48(D1):D704-D715
pubmed: 31701156
N Engl J Med. 2015 Jun 4;372(23):2235-42
pubmed: 26014595
Genet Med. 2019 Aug;21(8):1699-1701
pubmed: 30670879
Genet Med. 2018 Sep;20(9):1054-1060
pubmed: 29300386
Hum Mutat. 2018 Nov;39(11):1581-1592
pubmed: 30311380
Hum Mutat. 2018 Nov;39(11):1517-1524
pubmed: 30192042
Genet Med. 2018 Nov;20(11):1334-1345
pubmed: 29493581
Genome Med. 2019 Dec 31;12(1):3
pubmed: 31892348
Hum Mutat. 2018 Nov;39(11):1525-1530
pubmed: 30311383
Hum Mutat. 2018 Nov;39(11):1690-1701
pubmed: 30311374
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
Hum Mutat. 2018 Nov;39(11):1593-1613
pubmed: 30311386
Blood Adv. 2019 Oct 22;3(20):2962-2979
pubmed: 31648317
Hum Mutat. 2018 Nov;39(11):1614-1622
pubmed: 30311389
Curr Protoc Hum Genet. 2019 Sep;103(1):e93
pubmed: 31479589
Genome Biol. 2019 Nov 4;20(1):223
pubmed: 31679514
Nucleic Acids Res. 2018 Jan 4;46(D1):D8-D13
pubmed: 29140470

Auteurs

Christine G Preston (CG)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA.

Matt W Wright (MW)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA.

Rao Madhavrao (R)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA.

Steven M Harrison (SM)

Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.

Jennifer L Goldstein (JL)

Department of Genetics, University of North Carolina, Chapel Hill, NC, 27599, USA.

Xi Luo (X)

Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, TX, 77030, USA.

Hannah Wand (H)

Center for Inherited Cardiovascular Disease, Stanford Health Care, Stanford, CA, 94305, USA.

Bryan Wulf (B)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA.

Gloria Cheung (G)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA.

Mark E Mandell (ME)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA.

Howard Tong (H)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA.

Shaung Cheng (S)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA.

Michael A Iacocca (MA)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA.

Arturo Lopez Pineda (AL)

Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, 94305, USA.

Alice B Popejoy (AB)

Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, 94305, USA.

Karen Dalton (K)

Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.

Jimmy Zhen (J)

Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.

Selina S Dwight (SS)

Grace Science LLC, Menlo Park, CA, 94025, USA.

Lawrence Babb (L)

Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.

Marina DiStefano (M)

Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.

Julianne M O'Daniel (JM)

Department of Genetics, University of North Carolina, Chapel Hill, NC, 27599, USA.

Kristy Lee (K)

Department of Genetics, University of North Carolina, Chapel Hill, NC, 27599, USA.

Erin R Riggs (ER)

Autism & Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA, 17837, USA.

Diane B Zastrow (DB)

Sutter Health, Mountain View, CA, 94040, USA.

Jessica L Mester (JL)

GeneDx Inc., Gaithersburg, MD, 20877, USA.

Deborah I Ritter (DI)

Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, TX, 77030, USA.

Ronak Y Patel (RY)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.

Sai Lakshmi Subramanian (SL)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.

Aleksander Milosavljevic (A)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.

Jonathan S Berg (JS)

Department of Genetics, University of North Carolina, Chapel Hill, NC, 27599, USA.

Heidi L Rehm (HL)

Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.

Sharon E Plon (SE)

Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, TX, 77030, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.

J Michael Cherry (JM)

Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.

Carlos D Bustamante (CD)

Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.

Helio A Costa (HA)

Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, MSOB x313, Stanford, CA, 94305, USA. hcosta@stanford.edu.
Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, 94305, USA. hcosta@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH